Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Regulatory News (USA)

Share Price Information for Baillie Gifford (USA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.80
Bid: 196.40
Ask: 197.00
Change: 4.60 (2.39%)
Spread: 0.60 (0.305%)
Open: 196.80
High: 197.60
Low: 193.00
Prev. Close: 192.20
USA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison update on Baillie Gifford US Growth Trust

4 Oct 2022 13:10

RNS Number : 7468B
Baillie Gifford US Growth Trust PLC
04 October 2022
 

London, UK, 4 October 2022

 

Edison issues update on Baillie Gifford US Growth Trust (USA)

Baillie Gifford US Growth Trust (USA) has seen its net asset value (NAV) significantly fall in 2022 as growth stocks have fallen out of favour with investors. In addition, USA's share price has moved to a material discount to NAV for the first time since launch in March 2018. As a long-term fundamental investor, Baillie Gifford believes that the current investment opportunities in long-duration, high-growth stocks provide a tremendous opportunity for conviction investors, which could lay the foundations for the long-term outperformance of the fund.

 

Baillie Gifford is well known for its growth investment style; however, the US team arguably take this further than almost any other team. Its relentless focus on identifying tomorrow's leaders, often at a very early stage of their development in nascent and dramatically evolving markets within what is possibly the most prominent growth market in the world, sets it apart from the majority of its peers. In addition, the material weighting towards unquoted investments adds a further layer of differentiation. In 2022, growth as a style has fallen dramatically out of favour, which has negatively affected USA investor returns in both NAV and share price terms. However, the collegiate management team and long-term process have been in place over many years, over which time investors have been well rewarded. There are clearly risks in owning in some cases pre-profit and unquoted investments, which may guide investors to consider the position size for investments of this nature within diversified portfolios. The current discount to NAV of 19% could prove to be an attractive level to add to or initiate positions in USA.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

David Holder +44 (0)77 9626 8072 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABDBDGSGGDGDS
Date   Source Headline
9th Nov 202312:22 pmRNSNet Asset Value(s)
8th Nov 20235:34 pmRNSTransaction in Own Shares
8th Nov 202312:17 pmRNSNet Asset Value(s)
7th Nov 202311:30 amRNSNet Asset Value(s)
6th Nov 202312:12 pmRNSNet Asset Value(s)
3rd Nov 20234:49 pmRNSHolding(s) in Company
3rd Nov 202312:29 pmRNSNet Asset Value(s)
2nd Nov 202311:33 amRNSNet Asset Value(s)
1st Nov 20232:05 pmRNSNet Asset Value(s)
31st Oct 202310:47 amRNSNet Asset Value(s)
30th Oct 202311:02 amRNSNet Asset Value(s)
27th Oct 202312:48 pmRNSNet Asset Value(s)
26th Oct 202312:17 pmRNSNet Asset Value(s)
25th Oct 202311:01 amRNSNet Asset Value(s)
24th Oct 202311:44 amRNSNet Asset Value(s)
23rd Oct 202311:10 amRNSNet Asset Value(s)
20th Oct 202312:18 pmRNSNet Asset Value(s)
19th Oct 202312:07 pmRNSNet Asset Value(s)
18th Oct 202311:04 amRNSNet Asset Value(s)
17th Oct 202311:07 amRNSNet Asset Value(s)
16th Oct 202311:57 amRNSNet Asset Value(s)
13th Oct 202311:23 amRNSNet Asset Value(s)
12th Oct 20231:02 pmRNSNet Asset Value(s)
11th Oct 202311:06 amRNSNet Asset Value(s)
10th Oct 202311:16 amRNSNet Asset Value(s)
9th Oct 202311:41 amRNSNet Asset Value(s)
6th Oct 202311:55 amRNSNet Asset Value(s)
5th Oct 202311:08 amRNSNet Asset Value(s)
4th Oct 202311:42 amRNSNet Asset Value(s)
3rd Oct 202311:13 amRNSNet Asset Value(s)
2nd Oct 202312:45 pmRNSNet Asset Value(s)
28th Sep 202312:16 pmRNSNet Asset Value(s)
27th Sep 202311:52 amRNSNet Asset Value(s)
26th Sep 202311:32 amRNSNet Asset Value(s)
26th Sep 20237:00 amEQSHgCapital Trust: Seizing ‘buy-and-build’ opportunities
25th Sep 202311:21 amRNSNet Asset Value(s)
25th Sep 20239:05 amEQSBaillie Gifford US Growth Trust: Investing in the rapidly approaching future
22nd Sep 20235:56 pmRNSBlock listing Interim Review
22nd Sep 202312:13 pmRNSNet Asset Value(s)
21st Sep 20234:49 pmRNSHolding(s) in Company
21st Sep 20233:56 pmRNSDirector Declaration
21st Sep 202312:16 pmRNSNet Asset Value(s)
20th Sep 202311:46 amRNSNet Asset Value(s)
19th Sep 202312:32 pmRNSNet Asset Value(s)
18th Sep 20232:42 pmRNSResult of AGM
18th Sep 202312:56 pmRNSNet Asset Value(s)
15th Sep 202312:30 pmRNSNet Asset Value(s)
14th Sep 202312:38 pmRNSNet Asset Value(s)
13th Sep 20231:02 pmRNSNet Asset Value(s)
12th Sep 202312:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.